FDA product code GZF: Stimulator, Peripheral Nerve, Implanted (Pain Relief)

GZF is the FDA product code for stimulator, peripheral nerve, implanted (pain relief). It is a Class II device, regulated under 21 CFR 882.5870 and reviewed by the Neurology panel. FDA has cleared 25 510(k) submissions under GZF, 7 in the last five years, from 11 different applicants. The average 510(k) review took 184 days (median 175); 268 days on average over the last three years. FDA has posted 7 recalls for GZF devices, 1 initiated in the last five years.

Classification

FieldValue
Device nameStimulator, Peripheral Nerve, Implanted (Pain Relief)
Device classClass II
Regulation21 CFR 882.5870
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)
ImplantYes

510(k) clearances per year for GZF

YearClearancesAvg. review days
2017187
20193164
2020282
20211339
20221244
20231341
20242322
20252218
20261265

Compare with all 510(k) review times · Search every GZF clearance

Top GZF applicants

ApplicantClearancesLatest
Medtronic Vascular82000-04-12
Bioness, Inc.42022-02-23
Bioventus, LLC32026-08-26
Boston Scientific Neuromodulation22024-08-21
Neuspera Medical, Inc.22023-04-11

6 more applicants have GZF clearances. See the full list in Caduvo.

Most recent GZF clearances

510(k)ApplicantDeviceDecision dateReview days
K253877Bioventus, LLCStimTrial Neuromodulation System2026-08-26265
K243782Bioventus, LLCStimTrial Neuromodulation System2025-07-16219
K243678Bioventus, LLCTalisMann Neuromodulation System2025-07-03218
K232415Boston Scientific NeuromodulationNalu Neurostimulation System for Peripheral Nerve Stimulation2024-08-21376
K233162CuronixFreedom Peripheral Nerve Stimulator (PNS) System2024-06-20267

Recalls for GZF devices

7 product recalls in 2 recall events; 1 initiated in the last five years and 7 still open. Most recent: 2024-06-03.

YearRecalls
20206
20241

Frequently asked questions

What is FDA product code GZF?

GZF is the FDA product code for stimulator, peripheral nerve, implanted (pain relief). It is a Class II device, regulated under 21 CFR 882.5870 and reviewed by the Neurology panel.

What device class is GZF?

Class II, regulation 21 CFR 882.5870. Typical premarket route: 510(k).

How long does a 510(k) take for product code GZF?

Across 25 cleared submissions the average was 184 days from receipt to decision (median 175).

Which companies have the most GZF clearances?

Medtronic Vascular (8); Bioness, Inc. (4); Bioventus, LLC (3); Boston Scientific Neuromodulation (2); Neuspera Medical, Inc. (2).

Have GZF devices been recalled?

Yes: 7 product recalls across 2 recall events; the most recent began 2024-06-03.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times